Nonalcoholic Fatty Liver Disease
Open Access
- 18 March 2020
- book chapter
- other
- Published by Springer Science and Business Media LLC
- p. 233-269
- https://doi.org/10.1007/164_2020_352
Abstract
Nonalcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of the metabolic syndrome (MetS) and comprises one of the largest health threats of the twenty-first century. In this chapter, we review the current state of knowledge of NAFLD and underline the striking similarities with atherosclerosis. We first describe current epidemiological data showing the staggering increase of NAFLD numbers and its related clinical and economic costs. We then provide an overview of pathophysiological hepatic processes in NAFLD and highlight the systemic aspects of NAFLD that point toward metabolic crosstalk between organs as an important cause of metabolic disease. Finally, we end by highlighting the currently investigated therapeutic approaches for NAFLD, which also show strong similarities with a range of treatment options for atherosclerosis.Keywords
This publication has 171 references indexed in Scilit:
- Variant in the glucokinase regulatory protein ( GCKR ) gene is associated with fatty liver in obese children and adolescentsHepatology, 2011
- A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitisJournal of Hepatology, 2011
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular diseaseNature, 2011
- High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trialHepatology, 2010
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic DiseaseCell, 2010
- Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosisNature Medicine, 2009
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2008
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver diseaseHepatology, 2005